Serge Van Calenbergh Selected Research

Serge Van Calenbergh Research Topics

Disease

7	Neoplasms (Cancer) 04/2024 - 07/2017
7	Infections 03/2022 - 09/2011
4	Chagas Disease (American Trypanosomiasis) 11/2022 - 01/2021
4	Tuberculosis (Tuberculoses) 09/2020 - 10/2006
3	Parasitemia 11/2022 - 01/2021
3	Starvation 01/2011 - 09/2008
2	African Trypanosomiasis (Nagana) 02/2023 - 01/2020
2	Communicable Diseases (Infectious Diseases) 01/2021 - 12/2018
2	Staphylococcal Infections 11/2017 - 10/2016
2	Inflammation (Inflammations) 04/2012 - 02/2008
2	Rheumatoid Arthritis 11/2009 - 02/2008
2	Experimental Arthritis 02/2008 - 08/2007
1	Bacterial Infections (Bacterial Infection) 04/2024
1	Listeriosis (Listeria Infection) 04/2024
1	Wounds and Injuries (Trauma) 09/2023
1	Neuroblastoma 02/2023
1	Trypanosomiasis 01/2022
1	Leishmaniasis 12/2021
1	Trichomonas Infections 11/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 12/2020
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 12/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 12/2020
1	Animal Disease Models 03/2020
1	Central Nervous System Diseases (CNS Diseases) 03/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Breast Neoplasms (Breast Cancer) 12/2016
1	Hepatitis 01/2014
1	Respiratory Hypersensitivity 04/2012
1	Asthma (Bronchial Asthma) 04/2012
1	Metaplasia 04/2012
1	Seizures (Absence Seizure) 01/2012
1	Neoplasm Metastasis (Metastasis) 06/2011

Drug/Important Bio-Agent (IBA)

6	NucleosidesIBA 02/2023 - 12/2009
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2018 - 09/2008
4	LigandsIBA 03/2020 - 08/2007
3	Messenger RNA (mRNA)IBA 04/2024 - 01/2019
3	fosmidomycinIBA 09/2023 - 09/2007
3	EnzymesIBA 12/2020 - 09/2011
3	dTMP kinaseIBA 09/2020 - 10/2006
3	Vancomycin FDA LinkGeneric 02/2017 - 10/2016
3	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 04/2012 - 02/2008
3	Peptide Hydrolases (Proteases)FDA Link 01/2011 - 09/2008
2	VaccinesIBA 04/2024 - 01/2021
2	mRNA VaccinesIBA 04/2024 - 01/2023
2	alpha-galactosylceramideIBA 04/2024 - 08/2007
2	OvalbuminIBA 01/2023 - 01/2019
2	Purine NucleosidesIBA 03/2022 - 11/2021
2	ThymidineIBA 09/2020 - 11/2007
2	hamamelitanninIBA 02/2017 - 10/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2012 - 11/2009
2	2- (4- acetoxyphenyl)- 2- chloro- N- methylethylamineIBA 04/2012 - 11/2009
2	Mevalonic Acid (Mevalonate)IBA 09/2011 - 09/2007
1	Phosphotransferases (Kinase)IBA 02/2023
1	Aurora Kinase AIBA 02/2023
1	Oncogene Proteins (Oncogene Protein)IBA 02/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Galactosylceramides (Galactocerebrosides)IBA 01/2023
1	Dihydrotachysterol (AT 10)IBA 11/2022
1	Antitrichomonal AgentsIBA 11/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	benzonidazole (benznidazole)IBA 01/2021
1	ArylsulfatasesIBA 12/2020
1	Monoclonal AntibodiesIBA 10/2020
1	Complement System Proteins (Complement)IBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 09/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2020
1	Alanine (L-Alanine)FDA Link 01/2020
1	Antisense OligonucleotidesIBA 01/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020
1	purineIBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	AntigensIBA 01/2019
1	Cancer VaccinesIBA 01/2019
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2019
1	Bacterial DNAIBA 12/2018
1	Antiviral Agents (Antivirals)IBA 07/2017
1	2- (4- morpholinoanilino)- 6- cyclohexylaminopurineIBA 12/2016
1	Tamoxifen FDA LinkGeneric 12/2016
1	Investigational DrugsIBA 12/2016
1	LeptinIBA 01/2014
1	Janus KinasesIBA 01/2014
1	Mitogen-Activated Protein KinasesIBA 01/2014
1	GlucocorticoidsIBA 04/2012
1	CollagenIBA 04/2012
1	Cocaine (Cocaine HCl)IBA 01/2012
1	Terpenes (Terpenoids)IBA 09/2011
1	Galactose (Galactopyranose)FDA LinkGeneric 06/2011
1	cinnamaldehyde (cinnamic aldehyde)FDA Link 01/2011

Therapy/Procedure

4	Therapeutics 02/2023 - 12/2021
1	Oral Administration 03/2022
1	Topical Administration 11/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2020